🇺🇸 FDA
Patent

US 8025887

Avirulent, immunogenic flavivirus chimeras

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 8025887 (Avirulent, immunogenic flavivirus chimeras) held by The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
Grant date
Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/53, A61K2039/70